ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Artificial intelligence for diabetic retinopathy screening, prediction and management

Gunasekeran, Dinesh V.; Ting, Daniel S. W.; Tan, Gavin S. W.; Wong, Tien Y.*
CURRENT OPINION IN OPHTHALMOLOGY2020-9DOI: 10.1097/ICU.0000000000000693
60被引8阅读
引用收藏
分享

摘要

Purpose of review Diabetic retinopathy is the most common specific complication of diabetes mellitus. Traditional care for patients with diabetes and diabetic retinopathy is fragmented, uncoordinated and delivered in a piecemeal nature, often in the most expensive and high-resource tertiary settings. Transformative new models incorporating digital technology are needed to address these gaps in clinical care. Recent findings Artificial intelligence and telehealth may improve access, financial sustainability and coverage of diabetic retinopathy screening programs. They enable risk stratifying patients based on individual risk of vision-threatening diabetic retinopathy including diabetic macular edema (DME), and predicting which patients with DME best respond to antivascular endothelial growth factor therapy. Progress in artificial intelligence and tele-ophthalmology for diabetic retinopathy screening, including artificial intelligence applications in 'real-world settings' and cost-effectiveness studies are summarized. Furthermore, the initial research on the use of artificial intelligence models for diabetic retinopathy risk stratification and management of DME are outlined along with potential future directions. Finally, the need for artificial intelligence adoption within ophthalmology in response to coronavirus disease 2019 is discussed. Digital health solutions such as artificial intelligence and telehealth can facilitate the integration of community, primary and specialist eye care services, optimize the flow of patients within healthcare networks, and improve the efficiency of diabetic retinopathy management.

学科与关键词

关键词
artificial intelligencediabetes mellitusdiabetic retinopathytelehealth
相关
加载中…
  • Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application
    Bellemo, Valentina; Lim, Gilbert; Rim, Tyler Hyungtaek; Tan, Gavin S. W.; Cheung, Carol Y.; Sadda, SriniVas; He, Ming-guang; Tufail, Adnan; Lee, Mong Li; Hsu, Wynne; Ting, Daniel Shu Wei*Current Diabetes Reports, 2019, 19(9): 72.被引 104
  • Digital innovations for retinal care in diabetic retinopathy
    Vujosevic, Stela*; Limoli, Celeste; Luzi, Livio; Nucci, PaoloActa Diabetologica, 2022, 59(12): 1521-1530.被引 9
  • Different fundus imaging modalities and technical factors in AI screening for diabetic retinopathy: a review
    Lim, Gilbert; Bellemo, Valentina; Xie, Yuchen; Lee, Xin Q.; Yip, Michelle Y. T.; Ting, Daniel S. W.*Eye and Vision, 2020, 7(1): 21.被引 53
查看全部 →

发表信息

论文状态
公开发表
期刊
CURRENT OPINION IN OPHTHALMOLOGY
发表日期
2020-09
卷期
第 31 卷, 第 5 期
页码
357-365
DOI
10.1097/ICU.0000000000000693
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIE
资助标注
Singapore Eye Research Institute; Duke-NUS Medical School; National Medical Research Council

作者

  • G

    Gunasekeran, Dinesh V. (第一作者)

  • T

    Ting, Daniel S. W.

查看全部 4 位作者收起作者
  • T

    Tan, Gavin S. W.

  • W

    Wong, Tien Y. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417